Immunoglobulin G (IgG) Attenuates Neuroinflammation and Improves Neurobehavioral Recovery After Cervical Spinal Cord Injury

Overview

Journal J Neuroinflammation

Publisher Biomed Central

Date 2012 Sep 25

PMID 22998664

Citations 30

Authors

Dung Hoang Nguyen

Newton Cho

Kajana Satkunendrarajah

James W Austin

Jian Wang

Michael G Fehlings

Affiliations

Soon will be listed here.

Abstract

Background: Evidence suggests that the inflammatory events in the acute phase of spinal cord injury (SCI) exacerbate the initial trauma to the cord leading to poor functional recovery. As a result, minimizing the detrimental aspects of the inflammatory response after SCI is a promising treatment strategy. In this regard, immunoglobulin G (IgG) from pooled human serum is a promising treatment candidate. Due to its putative, though poorly characterized immuno-modulatory effects, IgG has been used clinically to treat neuroinflammatory disorders such as Guillain-Barré syndrome, but its effects in neurotrauma remain largely unexplored.

Methods: This study examines the potential neuroprotective effects of IgG in a well-characterized cervical model of SCI. Female Wistar rats were subject to moderate-severe clip compression injury at the C7-T1 level. IgG (0.4 g/kg) or saline was injected intravenously to randomly selected animals at 15 min post SCI. At several time points post SCI, biochemical assays, histology and immunohistochemistry analyses, and neurobehavioral assessments were used to examine the neuroprotective effects of IgG at the molecular, cellular, and neurobehavioral levels.

Results: We found that intravenous treatment of IgG following acute clip-compression SCI at C7-T1 significantly reduced two important inflammatory cytokines: interleukin (IL)-1β and IL-6. This early reduction in pro-inflammatory signaling was associated with significant reductions in neutrophils in the spinal cord and reductions in the expression of myeloperoxidase and matrix metalloproteinase-9 in the injured spinal cord at 24 h after SCI. These beneficial effects of IgG were associated with enhanced tissue preservation, improved neurobehavioral recovery as measured by the BBB and inclined plane tests, and enhanced electrophysiological evidence of central axonal conduction as determined by motor-evoked potentials.

Conclusion: The findings from this study indicate that IgG is a novel immuno-modulatory therapy which shows promise as a potential treatment for SCI.

Citing Articles

Administration of anti-GFAP antibodies increases CGRP expression and increases pain hypersensitivity in spinal cord injured animals.

Hergenroeder G, Molina S, Herrera J Int J Immunopathol Pharmacol. 2025; 39:3946320251320754.

PMID: 40019103 PMC: 11873870. DOI: 10.1177/03946320251320754.

The eATP/P2×7R Axis Drives Quantum Dot-Nanoparticle Induced Neutrophil Recruitment in the Pulmonary Microcirculation.

Li C, Liu Q, Han L, Zhang H, Immler R, Rathkolb B Adv Sci (Weinh). 2024; 11(45):e2404661.

PMID: 39364760 PMC: 11615809. DOI: 10.1002/advs.202404661.

Role of dendritic cells in spinal cord injury.

Han X, Zhang M, Yan L, Fu Y, Kou H, Shang C CNS Neurosci Ther. 2024; 30(3):e14593.

PMID: 38528832 PMC: 10964036. DOI: 10.1111/cns.14593.

Oxidative Post-translational Protein Modifications upon Ischemia/Reperfusion Injury.

Binek A, Castans C, Jorge I, Bagwan N, Rodriguez J, Fernandez-Jimenez R Antioxidants (Basel). 2024; 13(1).

PMID: 38247530 PMC: 10812827. DOI: 10.3390/antiox13010106.

High-dose IgG suppresses local inflammation and facilitates functional recovery after olfactory system injury.

Nishida K, Kobayashi M, Ishigami E, Takeuchi K Ann Clin Transl Neurol. 2022; 9(6):770-777.

PMID: 35588199 PMC: 9186131. DOI: 10.1002/acn3.51554.

References

BAINTON D, Farquhar M . Differences in enzyme content of azurophil and specific granules of polymorphonuclear leukocytes. II. Cytochemistry and electron microscopy of bone marrow cells. J Cell Biol. 1968; 39(2):299-317. PMC: 2107532. DOI: 10.1083/jcb.39.2.299. View

Taoka Y, Okajima K, Murakami K, Johno M, NARUO M . Role of neutrophil elastase in compression-induced spinal cord injury in rats. Brain Res. 1998; 799(2):264-9. DOI: 10.1016/s0006-8993(98)00459-4. View

Tonai T, Shiba K, Taketani Y, Ohmoto Y, Murata K, Muraguchi M . A neutrophil elastase inhibitor (ONO-5046) reduces neurologic damage after spinal cord injury in rats. J Neurochem. 2001; 78(5):1064-72. DOI: 10.1046/j.1471-4159.2001.00488.x. View

Blight A . Delayed demyelination and macrophage invasion: a candidate for secondary cell damage in spinal cord injury. Cent Nerv Syst Trauma. 1985; 2(4):299-315. DOI: 10.1089/cns.1985.2.299. View

Bao F, Chen Y, Dekaban G, Weaver L . An anti-CD11d integrin antibody reduces cyclooxygenase-2 expression and protein and DNA oxidation after spinal cord injury in rats. J Neurochem. 2004; 90(5):1194-204. DOI: 10.1111/j.1471-4159.2004.02580.x. View

Arumugam T, Tang S, Lathia J, Cheng A, Mughal M, Chigurupati S . Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death. Proc Natl Acad Sci U S A. 2007; 104(35):14104-9. PMC: 1955802. DOI: 10.1073/pnas.0700506104. View

Taoka Y, Okajima K, Uchiba M, Murakami K, Kushimoto S, Johno M . Role of neutrophils in spinal cord injury in the rat. Neuroscience. 1997; 79(4):1177-82. DOI: 10.1016/s0306-4522(97)00011-0. View

Midha R, Fehlings M, Tator C, Saint-Cyr J, Guha A . Assessment of spinal cord injury by counting corticospinal and rubrospinal neurons. Brain Res. 1987; 410(2):299-308. DOI: 10.1016/0006-8993(87)90328-3. View

Okada S, Nakamura M, Mikami Y, Shimazaki T, Mihara M, Ohsugi Y . Blockade of interleukin-6 receptor suppresses reactive astrogliosis and ameliorates functional recovery in experimental spinal cord injury. J Neurosci Res. 2004; 76(2):265-76. DOI: 10.1002/jnr.20044. View

10.

Pineau I, Lacroix S . Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J Comp Neurol. 2006; 500(2):267-85. DOI: 10.1002/cne.21149. View

11.

Allan S, Rothwell N . Cytokines and acute neurodegeneration. Nat Rev Neurosci. 2001; 2(10):734-44. DOI: 10.1038/35094583. View

12.

Peterson G . Review of the Folin phenol protein quantitation method of Lowry, Rosebrough, Farr and Randall. Anal Biochem. 1979; 100(2):201-20. DOI: 10.1016/0003-2697(79)90222-7. View

13.

Kwon B, Sekhon L, Fehlings M . Emerging repair, regeneration, and translational research advances for spinal cord injury. Spine (Phila Pa 1976). 2010; 35(21 Suppl):S263-70. DOI: 10.1097/BRS.0b013e3181f3286d. View

14.

Stangel M, Pul R . Basic principles of intravenous immunoglobulin (IVIg) treatment. J Neurol. 2006; 253 Suppl 5:V18-24. DOI: 10.1007/s00415-006-5003-1. View

15.

Stirling D, Khodarahmi K, Liu J, McPhail L, McBride C, Steeves J . Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J Neurosci. 2004; 24(9):2182-90. PMC: 6730425. DOI: 10.1523/JNEUROSCI.5275-03.2004. View

16.

Nashmi R, Imamura H, Tator C, Fehlings M . Serial recording of somatosensory and myoelectric motor evoked potentials: role in assessing functional recovery after graded spinal cord injury in the rat. J Neurotrauma. 1997; 14(3):151-9. DOI: 10.1089/neu.1997.14.151. View

17.

Gok B, Sciubba D, Okutan O, Beskonakli E, Palaoglu S, Erdamar H . Immunomodulation of acute experimental spinal cord injury with human immunoglobulin G. J Clin Neurosci. 2009; 16(4):549-53. DOI: 10.1016/j.jocn.2008.04.024. View

18.

Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, Ghezzi P . Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity. 1997; 6(3):315-25. DOI: 10.1016/s1074-7613(00)80334-9. View

19.

Noble L, Donovan F, Igarashi T, Goussev S, Werb Z . Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J Neurosci. 2002; 22(17):7526-35. PMC: 2792199. View

20.

Campbell S, Wilcockson D, Butchart A, Perry V, Anthony D . Altered chemokine expression in the spinal cord and brain contributes to differential interleukin-1beta-induced neutrophil recruitment. J Neurochem. 2002; 83(2):432-41. DOI: 10.1046/j.1471-4159.2002.01166.x. View